3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Classical hematology
1
Conditions
Lymphoma, Follicular
1
Hemophilia A
1
Interventions
Rituximab
6
Polymerase Chain Reaction
6
Amplified Fragment Length Polymorphism Analysis
6
Gene Expression Profiling
5
obinutuzumab
4
Surveys and Questionnaires
4
Psychiatric Rehabilitation
4
Microarray Analysis
4
Immunohistochemistry
4
Flow Cytometry
4
Therapeutics
3
Immunoenzyme Techniques
3
Drug Therapy
3
tisagenlecleucel
2
duvelisib
2
Prednisone
2
Lenalidomide
2
Influenza Vaccines
2
Immunologic Techniques
2
Echocardiography
2
Blood Specimen Collection
2
zanubrutinib
1
tazemetostat
1
relmacabtagene autoleucel
1
pomalidomide
1
ibritumomab tiuxetan
1
deucravacitinib
1
Watchful Waiting
1
Waiting Lists
1
Vincristine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Lymphoma, Follicular
×
Deamino Arginine Vasopressin
×
Clear all
NCT05628558
2022-11-28
GIDEMHA
Groupe Maladies hémorragiques de Bretagne
Unknown
800 enrolled